496 related articles for article (PubMed ID: 16110324)
21. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
Shui Y; Guan ZB; Zhang SQ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
[TBL] [Abstract][Full Text] [Related]
22. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
23. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice.
Karaca G; Swiderska-Syn M; Xie G; Syn WK; Krüger L; Machado MV; Garman K; Choi SS; Michelotti GA; Burkly LC; Ochoa B; Diehl AM
PLoS One; 2014; 9(1):e83987. PubMed ID: 24416188
[TBL] [Abstract][Full Text] [Related]
24. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
[TBL] [Abstract][Full Text] [Related]
25. TWEAK and Fn14: new molecular targets for cancer therapy?
Winkles JA; Tran NL; Berens ME
Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
[TBL] [Abstract][Full Text] [Related]
26. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice.
Ho DH; Vu H; Brown SA; Donohue PJ; Hanscom HN; Winkles JA
Cancer Res; 2004 Dec; 64(24):8968-72. PubMed ID: 15604260
[TBL] [Abstract][Full Text] [Related]
27. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury.
Akhurst B; Matthews V; Husk K; Smyth MJ; Abraham LJ; Yeoh GC
Hepatology; 2005 Feb; 41(2):327-35. PubMed ID: 15660390
[TBL] [Abstract][Full Text] [Related]
28. Tweak induces mammary epithelial branching morphogenesis.
Michaelson JS; Cho S; Browning B; Zheng TS; Lincecum JM; Wang MZ; Hsu YM; Burkly LC
Oncogene; 2005 Apr; 24(16):2613-24. PubMed ID: 15735761
[TBL] [Abstract][Full Text] [Related]
29. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
31. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.
Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J
Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147
[TBL] [Abstract][Full Text] [Related]
32. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration.
Girgenrath M; Weng S; Kostek CA; Browning B; Wang M; Brown SA; Winkles JA; Michaelson JS; Allaire N; Schneider P; Scott ML; Hsu YM; Yagita H; Flavell RA; Miller JB; Burkly LC; Zheng TS
EMBO J; 2006 Dec; 25(24):5826-39. PubMed ID: 17124496
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.
Michaelson JS; Burkly LC
Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634
[TBL] [Abstract][Full Text] [Related]
34. Direct effects of interleukin-6 on liver progenitor oval cells in culture.
Matthews VB; Klinken E; Yeoh GC
Wound Repair Regen; 2004; 12(6):650-6. PubMed ID: 15555057
[TBL] [Abstract][Full Text] [Related]
35. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.
Ebihara N; Nakayama M; Tokura T; Iwatsu M; Ushio H; Murakami A
Curr Eye Res; 2009 Oct; 34(10):836-44. PubMed ID: 19895311
[TBL] [Abstract][Full Text] [Related]
36. TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis.
Molano A; Lakhani P; Aran A; Burkly LC; Michaelson JS; Putterman C
Immunol Lett; 2009 Aug; 125(2):119-28. PubMed ID: 19573558
[TBL] [Abstract][Full Text] [Related]
37. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
Yepes M; Winkles JA
Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
[TBL] [Abstract][Full Text] [Related]
39. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
Mueller AM; Pedré X; Kleiter I; Hornberg M; Steinbrecher A; Giegerich G
J Neuroimmunol; 2005 Feb; 159(1-2):55-65. PubMed ID: 15652403
[TBL] [Abstract][Full Text] [Related]
40. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]